{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:15:20Z","timestamp":1787004920298,"version":"build-2736575974"},"reference-count":44,"publisher":"Georg Thieme Verlag KG","issue":"02","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Neuropsiquiatr"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hereditary transthyretin amyloidosis (ATTRv) is a rare, autosomal dominant, inherited disease caused by variants in the gene encoding the transthyretin (TTR) protein. These variants lead to TTR tetramer destabilization, resulting in the formation and progressive deposition of insoluble amyloid fibrils in various tissues, including those of the central nervous system (CNS). Although previously neglected, the recognition of CNS involvement in ATTRv has become progressively relevant due to prolonged patient survival and the ineffectiveness of the current therapies in addressing CNS synthesis of TTR. The first descriptions of the pathological involvement of the CNS in ATTRv date from the 1960s; however, this topic has not been fully explored. In the present article, the main CNS clinical manifestations of ATTRv, such as transient focal neurological episodes, bleeding complications, leptomeningeal amyloidosis, and cognitive impairment, are reviewed, and the phenotypic variability of this condition is highlighted. A literature review of the PubMed\/Medline database was conducted using the following keywords: hereditary amyloidosis, transthyretin amyloidosis, familial amyloidosis, central nervous system, neurological manifestations, leptomeningeal amyloidosis, cognition, and cognitive impairment. Studies published in the last 15 years, including review articles, prospective observational studies, experimental studies and clinical trials, were evaluated. Improving our understanding of CNS involvement in ATTRv will enable the early identification of neurological symptoms in this condition, which will enhance the understanding of the pathophysiological mechanisms and boost the advancement of research, expanding potential treatments and improving the quality of life of these individuals.<\/jats:p>","DOI":"10.1055\/s-0046-1817041","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:57:23Z","timestamp":1774310243000},"page":"001-010","source":"Crossref","is-referenced-by-count":1,"title":["Central Nervous System Manifestations Associated with Hereditary Transthyretin Amyloidosis: a Narrative Review"],"prefix":"10.1055","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8562-5848","authenticated-orcid":false,"given":"Pedro Ivo Machado Campos de Araujo","family":"Costa","sequence":"additional","affiliation":[{"name":"Universidade Federal de Juiz de Fora, Faculdade de Medicina, Programa de P\u00f3s-Gradua\u00e7\u00e3o em Sa\u00fade, Juiz de Fora MG, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6898-2790","authenticated-orcid":false,"given":"Marcelo Maroco","family":"Cruzeiro","sequence":"additional","affiliation":[{"name":"Universidade Federal de Juiz de Fora, Faculdade de Medicina, Departamento de Cl\u00ednica M\u00e9dica, Juiz de Fora MG, Brazil."},{"name":"Universidade Federal de Juiz de Fora, Faculdade de Medicina, Juiz de Fora MG, Brazil."},{"name":"Universidade Federal de Juiz de Fora, Hospital Universit\u00e1rio, Juiz de Fora MG, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6161-5963","authenticated-orcid":false,"given":"Arise Garcia de Siqueira","family":"Galil","sequence":"additional","affiliation":[{"name":"Universidade Federal de Juiz de Fora, Faculdade de Medicina, Juiz de Fora MG, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6145-9868","authenticated-orcid":false,"given":"Thiago Cardoso","family":"Vale","sequence":"additional","affiliation":[{"name":"Universidade Federal de Juiz de Fora, Faculdade de Medicina, Programa de P\u00f3s-Gradua\u00e7\u00e3o em Sa\u00fade, Juiz de Fora MG, Brazil."},{"name":"Universidade Federal de Juiz de Fora, Faculdade de Medicina, Departamento de Cl\u00ednica M\u00e9dica, Juiz de Fora MG, Brazil."},{"name":"Universidade Federal de Juiz de Fora, Faculdade de Medicina, Juiz de Fora MG, Brazil."},{"name":"Universidade Federal de Juiz de Fora, Hospital Universit\u00e1rio, Juiz de Fora MG, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"issue":"02","key":"ref1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1080\/13506129.2017.1335639","article-title":"Cognitive impairment in liver transplanted patients with transthyretin-related hereditary amyloid polyneuropathy","volume":"24","author":"V F Castro","year":"2017","journal-title":"Amyloid"},{"issue":"06","key":"ref2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/ane.13507","article-title":"An Exploratory Study of Cognitive Involvement in Hereditary Transthyretin Amyloidosis","volume":"144","author":"H Durmu\u015f","year":"2021","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"ref3","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1007\/s00415-013-7051-7","article-title":"Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy","volume":"260","author":"T Coelho","year":"2013","journal-title":"J Neurol"},{"issue":"01","key":"ref4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s42466-021-00155-8","article-title":"Are we creating a new phenotype? Physiological barriers and ethical considerations in the treatment of hereditary transthyretin-amyloidosis","volume":"3","author":"M F Dohrn","year":"2021","journal-title":"Neurol Res Pract"},{"issue":"24","key":"ref5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1212\/WNL.0000000000012965","article-title":"CNS Involvement in Hereditary Transthyretin Amyloidosis","volume":"97","author":"L Sousa","year":"2021","journal-title":"Neurology"},{"issue":"02","key":"ref6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/jnnp-2014-308107","article-title":"CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings","volume":"86","author":"L F Maia","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"05","key":"ref7","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s10072-019-04176-9","article-title":"The frequency of central nervous system complications in the Cypriot cohort of ATTRV30M neuropathy transplanted patients","volume":"41","author":"E Dardiotis","year":"2020","journal-title":"Neurol Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.wneu.2017.12.096","article-title":"Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation","volume":"111","author":"F Mathieu","year":"2018","journal-title":"World Neurosurg"},{"issue":"03","key":"ref9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1055\/s-0043-1764412","article-title":"Brazilian consensus for diagnosis, management and treatment of hereditary transthyretin amyloidosis with peripheral neuropathy: second edition","volume":"81","author":"M V Pinto","year":"2023","journal-title":"Arq Neuropsiquiatr"},{"issue":"02","key":"ref10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy","volume":"390","author":"J D Gillmore","year":"2024","journal-title":"N Engl J Med"},{"issue":"01","key":"ref11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jcph.2337","article-title":"Pharmacokinetics and Pharmacodynamics of GalNAc-Conjugated siRNAs","volume":"64","author":"G An","year":"2024","journal-title":"J Clin Pharmacol"},{"issue":"04","key":"ref12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/13506129.2016.1256282","article-title":"Efficiency of silencing RNA for removal of transthyretin V30M in a TTR leptomeningeal animal model","volume":"23","author":"P Gon\u00e7alves","year":"2016","journal-title":"Amyloid"},{"issue":"08","key":"ref13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1212\/WNL.0000000000003001","article-title":"Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis","volume":"87","author":"Y Sekijima","year":"2016","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/13506129.2019.1583199","article-title":"Comparison of clinical features in transient focal neurological episodes between hereditary transthyretin type and A\u03b2 type cerebral amyloid angiopathy","volume":"26","author":"M Nakajima","year":"2019","journal-title":"Amyloid"},{"issue":"01","key":"ref15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00401-022-02501-9","article-title":"Neuropathology of central nervous system involvement in TTR amyloidosis","volume":"145","author":"R Taipa","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"01","key":"ref16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/jcbfm.2015.88","article-title":"Ischemic brain injury in cerebral amyloid angiopathy","volume":"36","author":"Y D Reijmer","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","author":"Y Ando","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"01","key":"ref18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/febs.15339","article-title":"Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis","volume":"288","author":"F Pinheiro","year":"2021","journal-title":"FEBS J"},{"issue":"03","key":"ref19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ana.410410305","article-title":"Transthyretin amyloidosis: a new mutation associated with dementia","volume":"41","author":"R B Petersen","year":"1997","journal-title":"Ann Neurol"},{"issue":"05","key":"ref20","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.humpath.2013.10.037","article-title":"The pathologic spectrum of oculoleptomeningeal amyloidosis with Val30Gly transthyretin gene mutation in a postmortem case","volume":"45","author":"S E Martin","year":"2014","journal-title":"Hum Pathol"},{"issue":"03","key":"ref21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/brain\/103.3.473","article-title":"Familial oculoleptomeningeal amyloidosis","volume":"103","author":"H Goren","year":"1980","journal-title":"Brain"},{"issue":"09","key":"ref22","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/jnnp-2014-308724","article-title":"Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments","volume":"86","author":"Y Sekijima","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"08","key":"ref23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/01616412.2023.2208470","article-title":"Central nervous system involvement in two siblings affected by hereditary transthyretin amyloidosis 30 years after liver transplantation: a model for gene-silencing therapies","volume":"45","author":"A Di Paolantonio","year":"2023","journal-title":"Neurol Res"},{"issue":"03","key":"ref24","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s10072-024-07846-5","article-title":"Exploring cognitive functions and brain structure in Hereditary Transthyretin amyloidosis using brain MRI and neuropsychological assessment","volume":"46","author":"I Senem","year":"2025","journal-title":"Neurol Sci"},{"issue":"06","key":"ref25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00415-025-13120-1","article-title":"Cognitive manifestations and brain integrity in hereditary transthyretin amyloidosis: a systematic review","volume":"272","author":"I Senem","year":"2025","journal-title":"J Neurol"},{"issue":"02","key":"ref26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00415-017-8668-8","article-title":"Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis","volume":"265","author":"AMd Silva","year":"2018","journal-title":"J Neurol"},{"issue":"04","key":"ref27","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/13506129.2019.1646639","article-title":"Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study","volume":"26","author":"S Bartier","year":"2019","journal-title":"Amyloid"},{"issue":"04","key":"ref28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/13506129.2019.1663814","article-title":"Association between hearing loss and hereditary ATTR amyloidosis","volume":"26","author":"S Bartier","year":"2019","journal-title":"Amyloid"},{"issue":"07","key":"ref29","doi-asserted-by":"publisher","first-page":"104524","DOI":"10.1016\/j.ejmg.2022.104524","article-title":"Involvement of cranial nerves in ATTR Ile127Val amyloidosis","volume":"65","author":"J ADS Batista","year":"2022","journal-title":"Eur J Med Genet"},{"issue":"01","key":"ref30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13256-024-04575-3","article-title":"Palinacousis in amyloidosis: exploring the hallucinatory phenomenon in brain pathology-a case report","volume":"18","author":"J Martins-Correia","year":"2024","journal-title":"J Med Case Rep"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"120165","DOI":"10.1016\/j.jns.2022.120165","article-title":"Magnetic resonance imaging-based scores of small vessel diseases: Associations with intracerebral haemorrhage location","volume":"434","author":"G Schwarz","year":"2022","journal-title":"J Neurol Sci"},{"issue":"01","key":"ref32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/jamaneurol.2021.3989","article-title":"Transient Focal Neurological Events in Cerebral Amyloid Angiopathy and the Long-term Risk of Intracerebral Hemorrhage and Death: A Systematic Review and Meta-analysis","volume":"79","author":"J M Sanchez-Caro","year":"2022","journal-title":"JAMA Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"816636","DOI":"10.3389\/fneur.2022.816636","article-title":"Cerebellar and Cerebral Amyloid Visualized by [18F]flutemetamol PET in Long-Term Hereditary V30M (p.V50M) Transthyretin Amyloidosis Survivors","volume":"13","author":"E I Uneus","year":"2022","journal-title":"Front Neurol"},{"issue":"02","key":"ref34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40120-015-0031-3","article-title":"A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis","volume":"4","author":"M W Cruz","year":"2015","journal-title":"Neurol Ther"},{"issue":"01","key":"ref35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis","volume":"379","author":"M D Benson","year":"2018","journal-title":"N Engl J Med"},{"issue":"08","key":"ref36","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/ene.14285","article-title":"Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial","volume":"27","author":"T H Brannagan","year":"2020","journal-title":"Eur J Neurol"},{"issue":"15","key":"ref37","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1001\/jama.2023.18688","article-title":"Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy","volume":"330","author":"T Coelho","year":"2023","journal-title":"JAMA"},{"issue":"01","key":"ref38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"D Adams","year":"2018","journal-title":"N Engl J Med"},{"issue":"01","key":"ref39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13506129.2022.2091985","article-title":"Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial","volume":"30","author":"D Adams","year":"2023","journal-title":"Amyloid"},{"issue":"04","key":"ref40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3233\/JND-200542","article-title":"Familial Oculo-Leptomeningeal Transthyretin Amyloidosis Caused by Leu55Arg Mutation","volume":"7","author":"F Kleefeld","year":"2020","journal-title":"J Neuromuscul Dis"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"123273","DOI":"10.1016\/j.jns.2024.123273","article-title":"TTR associated leptomeningeal amyloidosis in a Sri Lankan patient","volume":"466","author":"M Muthukumarasamy","year":"2024","journal-title":"J Neurol Sci"},{"issue":"10","key":"ref42","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/jnen\/nlaa075","article-title":"Oculoleptomeningeal Amyloidosis Due to Transthyretin p.Y89H (Y69H) Variant","volume":"79","author":"G S Quintanilha","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"issue":"05","key":"ref43","doi-asserted-by":"publisher","first-page":"528","DOI":"10.5935\/0004-2749.20220099","article-title":"Ophthalmological manifestations of hereditary transthyretin amyloidosis","volume":"85","author":"FdAA Gondim","year":"2022","journal-title":"Arq Bras Oftalmol"},{"issue":"01","key":"ref44","first-page":"18","article-title":"Polineuropatia amiloidotica familiar ocasiona altera\u00e7\u00f5es cognitivas?","volume":"15","author":"D M Torres","year":"2021","journal-title":"Cadernos ESP"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0046-1817041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:57:32Z","timestamp":1774310252000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0046-1817041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":44,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2026,2,27]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["s00461817041"],"URL":"https:\/\/doi.org\/10.1055\/s-0046-1817041","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0004-282X","1678-4227"],"issn-type":[{"value":"0004-282X","type":"print"},{"value":"1678-4227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}